Vasopressin: Why not in severe traumatic disease? Jesús Abelardo Barea-Mendoza; Juan Antonio Llompart-Pou; Adrian Marcos-Morales; Mario Chico-Fernández;

Ten take-home messages on vasopressin use in critically ill patients Ricard Ferrer; Pedro Castro; Carol Lorencio; Josman Monclou; Pilar Marcos; Ana Ochagavia; Juan Carlos Ruíz-Rodríguez; Josep Trenado; Christian Villavicencio; Juan Carlos Yébenes; Lluís Zapata;

Short- and long-term mortality in critically ill patients with solid cancer. The Vall d¿Hebron Intensive Care Unit-Vall d¿Hebron Institute of Oncology Cohort: a retrospective study Cándido Díaz-Lagares; Alejandra García-Roche; Andrés Pacheco; Javier Ros; Erika P. Plata-Menchaca; Adaia Albasanz; David Pérez; Nadia Saoudi; Isabel Ruiz-Camps; Elena Élez; Ricard Ferrer;